One in three Australians suffer from poor quality sleep. New research suggests sleep deprivation is costing the Australian economy more than $5.1 billion a year in both direct and indirect costs.
Many people with asthma have sensitivities to certain drugs that can precipitate an asthma attack. If you have asthma, you need to be aware of which medications may be triggers. You do not need to avoid these medications unless you know they are asthma triggers for you. If these medications have never triggered your asthma, it is still best to take the medications with caution because a reaction can occur at any time.
1 in 2 Australians will be diagnosed with cancer by the age of 85, with more than 60% of cancer patients surviving more than five years after diagnosis.According to a recent US study the hidden psychological scars caused by the diagnosis of cancer can leave scaring akin to that inflicted by war, with the impact in some cases lasting for years.Pulmonary Fibrosis Part I
In this article a practical approach is given for the interpretation of high resolution CT (HRCT) examinations. We will discuss the following subjects:
- Anatomy of the secondary lobule
- Basic HRCT patterns
- Distribution of abnormalities
- Differential diagnosis of interstitial lung diseases
Pulmonary Fibrosis Part II
In this review we present the key findings in the most common interstitial lung diseases. There are numerous interstitial lung diseases, but in clinical practice only about ten diseases account for approximately 90% of cases
Lung Cancer Part 1
In 2009 a new Lung cancer lymph node map was proposed by the International Association for the Study of Lung Cancer (IASLC). In this article we provide illustrations and CT-images for a better understanding of this IASLC lymph node map.
Lung Cancer Part II
Lungcancer is classified into two categories: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). NSCLC is a group of primary lung neoplasms with the same staging system and therapy and can be cured with surgical resection if it is in an early stage.
In this review we will discuss:
- TNM-classification
- T-staging with CT
- N- and M-staging with CT
- PET-CT
The Solitary Pulmonary Nodule (solitary 'mass')
The differential diagnosis of a solitary pulmonary nodule is broad and management depends on whether the lesion is benign or malignant. In this overview we will discuss some of the new features that can help to differentiate between benign and malignant nodules based upon CT and PET-CT findings.
Mediastinal Masses
This review will focus on how to narrow down the differential diagnosis of mediastinal lesions by localizing and characterizing them.